how long to lose weight tirzepatide 10–70 lbs on GLP-1 Tirzepatide? What to Know Before Starting

3 In the STEP-1 trial of semaglutide for the treatment of obesity, secondary findings showed improvements in the GLP-1 treatment group in systolic blood pressure (-6.16mm Hg) and diastolic blood pressure (-2.83mm Hg)

Side effects, when they occur, are commonly gastrointestinal and often improve with time and supportive habits

Every patient responds differently to peptide therapy

The researchers optimized the potency ratio between the three receptors and used a protraction strategy that allows for once-weekly dosing, then tested the drugs in diet-induced obese mice

Semaglutide injections should not be stopped without consulting your healthcare provider